Plexus (PLXS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Zacks Apri Zacks
Plexus (PLXS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended March 2026, Plexus (PLXS) reported revenue of $1.16 billion, up 18.7% over the same period last year. EPS came in at $2.05, compared to $1.66 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $1.13 billion, representing a surprise of +2.99%. The company delivered an EPS surprise of +9.43%, with the consensus EPS estimate being $1.87.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Plexus performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenue- Market Sector- Healthcare/Life Sciences: $473 million compared to the $478.74 million average estimate based on two analysts. The reported number represents a change of +15.1% year over year. Revenue- Market Sector- Aerospace/Defense: $212 million compared to the $189.08 million average estimate based on two analysts. The reported number represents a change of +23.3% year over year. Revenue- Market Sector- Industrial: $479 million compared to the $462.27 million average estimate based on two analysts. The reported number represents a change of +20.7% year over year.

View all Key Company Metrics for Plexus here>>>

Shares of Plexus have returned +21.6% over the past month versus the Zacks S&P 500 composite's +12.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."

Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention. 

See them now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Plexus Corp. (PLXS): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research